상품명칭 |
[(2R,3S,4R,5R)-5-(6-아미노푸린-9-일)-4-히드록시-2-[[히드록시-[히드록시-[3-히드록시-3-[2-[[(E)-3-(4-히드록시페닐)프로펠-2-에노일]설파닐에틸카르바모일]에틸카르바모일]-2,2-디메틸-프로폭시]포스포릴]옥시-포스포릴]옥시메틸]옥솔란-3-일]옥시포스폰산 |
별명 |
p-쿠마로일-CoA; 4-쿠마로일-코엔자임 A; S-{17-[(2R,3S,4R,5R)-5-(6-아미노-9H-퓨린-9-일)-4-하이드록시-3-(포스포노옥시)테트라하이드로푸란-2-일]-9,13,15-트리하이드록시-10,10-디메틸-13,15-디옥시-4,8-디옥소-12,14,16-트리옥사-3,7-디아자-13,15-디포스파헵타덱-1-일} (2E)-3-(4-하이드록시페닐)프로프롭-2-에네티오에이트(비바람직한 명칭); S-{(9R)-17-[(2R,3S,4R,5R)-5-(6-아미노-9H-푸린-9-일)-4-히드록시-3-(포스포노옥시)테트라히드로푸란-2-일]-9,13,15-트리하이드록시-10,10-디메틸-13,15-디옥시-4,8-디옥소-12,14,16-트리옥사-3,7-디아자-13,15-디포스파헵타덱-1-일} (2E)-3-(4-히드록시페닐)프로프-2-에네티오에이트(비바람직한 명칭) |
영문 이름 |
[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-2-[[hydroxy-[hydroxy-[3-hydroxy-3-[2-[2-[(E)-3-(4-hydroxyphenyl)prop-2-enoyl]sulfanylethylcarbamoyl]ethylcarbamoyl]-2,2-dimethyl-propoxy]phosphoryl]oxy-phosphoryl]oxymethyl]oxolan-3-yl]oxyphosphonic acid;p-coumaroyl-CoA; 4-coumaroyl-coenzyme A; S-{17-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl} (2E)-3-(4-hydroxyphenyl)prop-2-enethioate (non-preferred name); S-{(9R)-17-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)tetrahydrofuran-2-yl]-9,13,15-trihydroxy-10,10-dimethyl-13,15-dioxido-4,8-dioxo-12,14,16-trioxa-3,7-diaza-13,15-diphosphaheptadec-1-yl} (2E)-3-(4-hydroxyphenyl)prop-2-enethioate (non-preferred name) |
분자식 |
C30H42N7O18P3S |
분자량 |
913.6769 |
InChI |
InChI=1/C30H42N7O18P3S/c1-30(2,25(42)28(43)33-10-9-20(39)32-11-12-59-21(40)8-5-17-3-6-18(38)7-4-17)14-52-58(49,50)55-57(47,48)51-13-19-24(54-56(44,45)46)23(41)29(53-19)37-16-36-22-26(31)34-15-35-27(22)37/h3-8,15-16,19,23-25,29,38,41-42H,9-14H2,1-2H3,(H,32,39)(H,33,43)(H,47,48)(H,49,50)(H2,31,34,35)(H2,44,45,46)/b8-5+/t19-,23-,24-,25+,29-/m1/s1 |
cas번호 |
119785-99-8 |
분자 구조 |
|
밀도 |
1.8g/cm3 |
굴절 지수 |
1.711 |
위험성 표시 |
|
리스크 규칙 |
|
보안 규칙 |
|
|